[Biopharmaceutical studies on neuroleptic butyrophenones. V. Effects of chronic treatment on adrenal and hepatic drug-metabolizing enzyme system in rats (author's transl)].
D000311:Adrenal Glands / Q000201:enzymology*; D000633:Aminopyrine N-Demethylase / Q000378:metabolism*; D000815:Aniline Hydroxylase / Q000378:metabolism*; D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology; D008099:Liver / Q000201:enzymology*; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D051381:Rats; D014272:Trifluperidol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology
D003577:Cytochrome P-450 Enzyme System; D000815:Aniline Hydroxylase; D001189:Aryl Hydrocarbon Hydroxylases; D000633:Aminopyrine N-Demethylase; D006220:Haloperidol; C023813:clofluperol; D014272:Trifluperidol